Widespread antibiotic resistance among important bacterial pathogens such as Staphylococcus aureus 1 calls for alternative routes of drug development. Interfering with crucial virulence determinants is considered a promising new approach to control bacterial infection 2 . Phenol-soluble modulins (PSMs) are peptide toxins with multiple key roles in pathogenesis [3] [4] [5] and have a major impact on the ability of highly virulent S. aureus to cause disease 3, 6 . However, targeting PSMs for therapeutic intervention is hampered by their multitude and diversity. Here we report that an ATP-binding cassette transporter with previously unknown function is responsible for the export of all PSMs, thus representing a single target for complete obstruction of PSM production. The transporter had a strong effect on virulence phenotypes, such as neutrophil lysis, and the extent of its effect on the development of S. aureus infection was similar to that of the sum of all PSMs. Notably, the transporter was essential for bacterial growth. Furthermore, it contributed to producer immunity toward secreted PSMs and defense against PSM-mediated bacterial interference. Our study reveals a noncanonical, dedicated secretion mechanism for an important class of toxins and identifies this mechanism as a comprehensive potential target for the development of drugs to efficiently inhibit the growth and virulence of pathogenic staphylococci.
Several observations point to the value of targeting PSMs for drug development. First, PSMs have multiple crucial roles in pathogenesis. They efficiently lyse red and white blood cells 3, 7, 8 , control biofilm development 4, 9, 10 and trigger receptor-mediated inflammatory responses 3, 11 . Importantly, despite recent discoveries indicating that PSMs-similarly to other important staphylococcal virulence molecules 12, 13 -are targeted by nonspecific mechanisms of human innate host defense 14, 15 , they have a major impact on disease progression 3, 6 . Second, essentially all pathogenic staphylococci secrete members of the PSM family 3, 7, 11, 16 . Third, PSMs are encoded in the core genome and are strongly expressed by most strains of a species 3, 11, 16 . However, staphylococci commonly secrete a series of PSMs that differ considerably in their amino acid sequences 3, 11, [16] [17] [18] . For example, S. aureus produces four different PSMα peptides (encoded in the psmα operon), two different PSMβ peptides (encoded in the psmβ operon) and the hld-encoded δ-toxin 3 . Consequently, it is extremely difficult to develop strategies to interfere broadly with PSM production or toxicity. However, all PSMs have structural features (for example, lack of a signal peptide) that suggest they share a previously unidentified, dedicated mechanism of secretion 3,7 that would provide a way to simultaneously target production of the entire PSM family. Therefore, we set out to identify the PSM export mechanism.
As the accessory gene regulator (Agr) exerts particularly strong control over PSM production 19 , we hypothesized that the PSM exporter is also regulated by the Agr system. Among the Agrcontrolled genes with potential transport functions 20 , we found only one candidate set of genes that, similarly to the psm genes, was present in all staphylococcal species but was absent from other bacteria ( Fig. 1a and Supplementary Fig. 1 ). Assuming that it participates in PSM secretion, we named this system Pmt for phenol-soluble modulin transporter. The Pmt system consists of four genes (pmtA, pmtB, pmtC and pmtD) encoding an ATP-binding cassette (ABC) transporter with two separate membrane parts (PmtB and PmtD) and two separate ATPases (PmtA and PmtC) ( Fig. 1a and Supplementary Figs. 2  and 3) . Among the Pmt proteins, the PmtB and PmtD sequences are highly specific for Staphylococcus spp.: a search of the protein BLAST (BLASTP) database for PmtB and PmtD showed pronounced similarity among Staphylococcus spp. (E values of 1 × 10 −19 and 1 × 10 −22 , respectively), whereas these sequences had no similarity with proteins from nonstaphylococcal organisms (maximal E values of 0.12 and 4.1, respectively).
To assess the involvement of pmt in PSM secretion, we first attempted to delete the pmt locus by allelic replacement in two S. aureus strains with high clinical importance and different genetic backgrounds (USA300 LAC and USA400 MW2) 21 (Supplementary  Table 1 ). However, we could not find a pmt deletion clone without forcing an agr mutation, which led us to hypothesize that the Pmt transporter not only facilitates PSM export but is also essential for bacterial survival when PSM peptides are expressed. To analyze the function of pmt, we therefore first removed all psm genes from the two S. aureus strains, after which deletion of pmt was successful, and then introduced plasmids for the expression of psm genes (Supplementary Table 1 ). This system was optimally suited to analyze the contribution of Pmt to PSM export without overexpression effects, as PSM production was approximately equal to or lower than that in the Essential Staphylococcus aureus toxin export system wild-type strains ( Supplementary Fig. 4 ), in which PSMs are expressed at extremely high levels ( Supplementary Fig. 5a,b) .
We found that secretion of all the S. aureus PSMs was strongly dependent on Pmt (Fig. 1b and Supplementary Fig. 6 ). Notably, analysis of the secreted protein profiles indicated that PSMs are the primary substrate of the Pmt transporter (Supplementary Fig. 5 ). Furthermore, except for the barely cytolytic, low-abundance PSMβ peptides 3, 7, 9 , expression of PSMs led to marked growth defects in the absence of pmt (Fig. 1c and Supplementary Fig. 7 ), confirming our hypothesis on the essentiality of pmt. PSM secretion was dependent on Walker A and B boxes, which are conserved nucleotide-binding domains that are crucial for the catalytic function of ABC transporters 22, 23 , demonstrating energy dependence and the direct involvement of Pmt in PSM export (Fig. 1d,e and Supplementary Figs. 2 and 8) . Moreover, consistent with the results obtained in S. aureus, secretion of PSMs was dependent on the presence of pmt in the heterologous host Lactococcus lactis ( Fig. 1f and Supplementary Fig. 9 ), and pmt was necessary for the growth of L. lactis with concomitant expression of psm genes ( Fig. 1g and Supplementary Fig. 9 ). Together our findings show that Pmt facilitates PSM export in a specific, energydriven fashion and is essential for growth under conditions of PSM production.
We then investigated further the underpinnings of the PSM-induced growth defects that developed in the absence of pmt. First, we found that in the absence of pmt, PSMs accumulate in the cytosol ( Fig. 2a and Supplementary Fig. 10 ). We could demonstrate this cytosolic accumulation for the most potent cytolysins among the S. aureus PSMs (PSMα2, PSMα3 and δ-toxin 3 ), whereas detection of other PSMs was difficult, probably owing to low production, degradation or nonspecific adhesion to cellular material. Second, cytosolic accumulation of PSMs was accompanied by abnormal cell division and severe damage to the cytoplasmic membrane ( Fig. 2b-d) . The multitude and severity of the observed effects are probably the result of the extraordinarily high production and distinctive surfactant characteristics of PSMs 3, 4, 7 , overwhelming the cytosolic protein degradation machinery and disrupting vital interactions between macromolecules.
Some PSMs, such as PSMδ and the δ-toxin produced by the abundant human colonizer Staphylococcus epidermidis 24 npg act as pore-forming antimicrobials against a series of microorganisms 25, 26 . Notably, Pmt efficiently protected S. aureus from the antimicrobial activities of the PSMs that it secretes (self PSMs), as well as from those produced by S. epidermidis (non-self PSMs) (Fig. 3) . These findings indicate that Pmt confers producer immunity toward self PSMs and provides resistance to non-self PSMs that may function as weapons of bacterial interference during co-colonization of the human host 25 . We then investigated the role of Pmt in virulence-associated phenotypes. Using expression of the peptides PSMα1 through PSMα4 (PSMα1-4) as the predominant cytolytic PSMs 3 , we found that Pmt significantly affects lysis of human neutrophils and erythrocytes and survival of S. aureus in human blood (Fig. 4a-c and Supplementary  Fig. 11 ). Of note, the results of the neutrophil lysis experiments, which we performed using live bacteria, indicate that PSMα peptides contribute significantly to the lysis of neutrophils after phagocytosis, a phenotype that is poorly understood on a mechanistic level. In the light of reports indicating inhibition of PSMs and other cytolytic agents by serum 14, 27 , these findings underscore the role that PSMs and Pmt have in circumventing elimination by human neutrophils. Furthermore, Pmt markedly affected biofilm development (Supplementary Fig. 12 ). These results show that Pmt affects key virulence-associated phenotypes similarly to the sum of all PSMs.
As the majority of S. aureus infections present as infections of the skin 28 , we used a mouse skin infection model to analyze the contribution of Pmt to disease progression. We infected mice with isogenic pmt-positive and -negative strains constitutively expressing the peptides PSMα1−4. Abscesses formed by the pmt-positive strain were significantly larger (during the first 5 d after infection) than those formed by the corresponding strain lacking the pmt genes (Fig. 4d) . Furthermore, in accordance with the strong contribution of PSMα peptides to abscess formation 3 and the somewhat lower production of PSMα peptides with the used plasmid-based expression system compared to the USA300 wild-type strain ( Supplementary Fig. 4) , the pmt-positive strain formed abscesses that were only slightly Figure 3 Pmt contributes to producer immunity and defense against PSM-based bacterial interference. Protective effects against S. aureus and S. epidermidis PSMs as determined by killing assays performed with a 3-h incubation of 10 6 colony-forming units (CFU) of bacteria and the addition of different concentrations of the various peptides in carbonatecontaining buffer 29 , which mimics in vivo conditions and has been used in previous studies on PSM antimicrobial activities 25, 26 . The strain designations are as in Figure 1 . All P values shown were calculated by t tests for comparison to the corresponding WT* sample. The means and s.e.m. of each group are shown. Fig. 11) . WT, the USA300 strain; all other strain designations are as in Figure 1 . (b) Hemolysis in culture filtrates after being concentrated and extracted with butanol (to remove the overlaying hemolytic activity of α-toxin 8 ) determined using incubation with human erythrocytes (left) or human blood agar plates (right). A 540 , absorbance at an optical density of 540 nm. (c) Survival of bacteria incubated with heparinized human blood (10 6 CFU per ml) for 60 min. (d) Abscess sizes (lesions and the surrounding inflamed areas) measured daily in groups of mice (n = 12 per group) subcutaneously injected at the dorsum with the indicated strains. Representative images of formed abscesses are also shown (right). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 determined by two-way ANOVA with Bonferroni post tests; only results comparing the two PSMα1-4-expressing strains are shown (see Supplementary Table 2 smaller than those formed by the USA300 wild-type strain. Moreover, abscesses formed by the pmt-negative strain were indistinguishable in size from those formed by the corresponding control strain, USA300, in which all psm genes were deleted (Supplementary Table 2 ). Bacterial numbers in the abscesses were significantly different between the wild-type and pmt-negative strains, confirming the differences found with abscess sizes (Fig. 4e) . These experiments demonstrate that Pmt is indispensable for the development of S. aureus skin infection. Pmt may have an even stronger effect on the pathogenic potential of the infecting S. aureus strain in a natural situation with wild type-level expression of all PSMs.
We have identified the system required for export of the PSM class of staphylococcal toxins. Although we performed our experiments in S. aureus, the high similarity of pmt genes among staphylococci strongly suggests that the Pmt system has the same role in other species. Given the extremely high amount of PSM peptides secreted by staphylococci, the Pmt ABC transporter is a bacterial peptide exporter with extraordinarily high efficiency. Our finding that PSM production in the absence of the Pmt export system leads to substantial growth defects indicates that PSM evolution was only possible with the coevolution of a dedicated transporter. This may explain why PSMs are limited to the genus Staphylococcus despite their relatively simple structure and the value they would presumably have for virulence in many other bacterial pathogens. We believe that the PSM exporter represents a drug target with exceptional potential value, as it not only facilitates secretion of an entire class of widespread staphylococcal toxins with key functions in virulence but is also essential for microbial growth and defense against bacterial interference (Fig. 4f,g ).
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Methods and any associated references are available in the online version of the paper.
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Bacterial strains, plasmids and growth conditions. The bacterial strains and plasmids used are described in Supplementary Table 1 . Transformation of S. aureus and L. lactis was performed by electroporation, as described 30, 31 . E. coli and S. aureus strains were grown in tryptic soy broth with the appropriate antibiotic selection at 37 °C and shaking at 180 r.p.m. L. lactis strains were grown in GM17 medium supplemented with 0.5% glucose with the appropriate antibiotic selection at 30 °C and shaking at 180 r.p.m. For induction, xylose (0.5%) or nisin (10 ng ml −1 ) was added. Bacterial cultures were inoculated to an optical density at 600 nm of 0.1 (for S. aureus) or 0.05 (for L. lactis) from precultures that were grown overnight.
Quantitative PSM detection. The amounts of PSM peptides were measured by reversed-phase HPLC/electrospray mass spectrometry (RP-HPLC/ESI-MS) using an 1100 HPLC system connected to an MSD Trap SL mass spectrometer (Agilent). Samples (100 µl) were injected onto a Zorbax SB-C8 2.3 mm × 30 mm column (Agilent), and a 0.1% trifluoroacetic acid (TFA) water and 0.1% TFA acetonitrile gradient was applied as follows (flow rate, 0.5 ml min −1 ); 10% acetonitrile from 0-2 min, 50% acetonitrile from 2-4 min, 50-100% acetonitrile linear gradient from 4-9 min, 100% acetonitrile from 9-13 min and 0% acetonitrile from 13-16 min. For the measurements of cytosolic PSMs, samples were dissolved in 6 M guanidinium chloride, 20 µl of sample was injected onto a µRPC C2/C18 ST 4.6/100 column (GE Healthcare), and a 0.1% TFA water and 0.1% TFA linear acetonitrile gradient was run over 50 min at 0.5 ml min −1 . Relative PSM production was determined by measuring the peak area of the extracted ion chromatogram corresponding to the multiply charged mass-to-charge (m/z) values of each PSM using QuantAnalysis software (Agilent). All PSM measurements were performed on cultures grown for 12 h (S. aureus), 8 h (L. lactis PSMα peptides and δ-toxin) or 6 h (L. lactis PSMβ peptides).
Construction of pmt deletion mutants and plasmids for expression of pmt and psm genes. Deletion of the pmt genes (pmtA, pmtB, pmtC and pmtD) was performed using a previously described allelic replacement procedure 32 . Briefly, ~1-kb regions upstream and downstream of the pmt genes were amplified from MW2 genomic DNA as a template using the PCR primer pairs pmtA-D-P1 and pmtA-D-P2, and pmtA-D-P3 and pmtA-D-P4, respectively (Supplementary Table 3) , and introducing att1 and att2 sites at the distal ends. The PCR fragments were fused together by overlap PCR and subsequently cloned into the vector pKOR1 (ref. 32) using a BP clonase kit (Invitrogen). The resulting vector was transformed into the strains of interest. The standard allelic replacement procedure was then performed as described 32 .
Plasmids to complement the pmt deletion by expression of the pmt genes were constructed by amplification of the pmt genes from MW2 genomic DNA with primers P3 and P4, digestion with Kpn1 and Hind3 and cloning into pRB473 or pMG36c. The natural promoter of the pmt genes was amplified with primers P5 and P6 and fused with the pmt PCR fragment before cloning into pRB473. Walker A and B site mutations in the pRBpmt plasmids were constructed using four-fragment fusion PCR, analogous subsequent digestion and cloning into pRB473.
The various psm genes were amplified using the primers indicated in Supplementary Table 3 ; PCR fragments were digested with the indicated enzymes and cloned into the appropriate vectors. For generation of the pTXα1-4 vector, the psmα1-4 fragment was obtained from vector pTX ∆ α1-4 by digestion with BamH1 and Mlu1 and cloned into pTX15.
Animal model of skin infection.
The mouse skin infection model was performed as described previously 3 . Briefly, female Crl:SKH1-hrBR mice were injected subcutaneously with approximately 2 × 10 7 bacterial cells in 50 µl of PBS in the left flank. The length and width of the abscess or lesion caused by the bacterial infection was measured with an electronic caliper daily for 14 d after infection and calculated using the formula length × width. Bacterial numbers in the abscesses were determined using isolation of the genomic DNA of harvested tissue samples and subsequent quantitative real-time PCR 33 of the gyrB gene 34 . All mouse experiments were performed at the animal care facility of the NIAID, building 33, and were in compliance with the guidelines of the NIAID/NIH Institutional Animal Care and Use Committee.
Hemolysis assay. Human blood was obtained from healthy volunteers in accordance with a protocol approved by the Institutional Review Board for Human Subjects, NIAID. Informed written consent was received from all human volunteers. Culture filtrates were concentrated by butanol extraction according to the procedures of Joo et al. 26 : 30 ml of bacterial culture filtrate was collected from bacterial cultures grown for 12 h. Butanol was added to the culture filtrate at a ratio of 1:3 by volume. The mixture was incubated at 37 °C for 2 h and then centrifuged at 3,700g for 10 min. The butanol phase was collected, dried in a vacuum concentrator and resuspended in 300 µl of 8 M urea. Fifteen microliters of the butanol extract was spotted onto human blood agar plates. The plates were incubated at 37 °C overnight and photographed. An 8 M urea control did not produce hemolysis. Alternatively, hemolytic activities were determined by incubating samples with human erythrocytes (2% (v/v) in Dulbecco's PBS) for 1 h at 37 °C. Hemolysis was determined by measuring the optical density at 540 nm using an ELISA reader. The assay was performed in duplicate.
Survival in human blood, neutrophil lysis and phagocytosis. Heparinized venous blood of healthy individuals was obtained with approval from the ethics committee of Huashan Hospital, Fudan University, Shanghai. All individuals gave informed consent before donating blood. For the determination of lysis, phagocytosis and survival rates, S. aureus strains were grown to the midexponential growth phase, washed and resuspended in sterile PBS at 10 5 CFU per µl. Then, 10 7 CFU of S. aureus in 100 µl PBS was pipetted slowly into 10 ml heparinized blood, mixed gently for 30 s and incubated at 37 °C. Blood smears at different time points were prepared, and cells were stained with a modified Wright-Giemsa stain. The total number of S. aureus (bound, ingested and those within a 10-µm distance of the neutrophils) was evaluated using 50 neutrophils per assay. Percentage phagocytosis was calculated using the following equation: number of ingested bacteria/(sum of PMN-associated bacteria, PMN-bound bacteria and ingested bacteria) × 100. Lysis of neutrophils was determined microscopically and evaluated as the number of lysed neutrophils per 100 neutrophils. To determine survival rates, 100 µl of heparinized blood samples were plated on tryptic soy agar containing 5% sheep blood for S. aureus detection.
As an alternative protocol to determine phagocytosis rates, S. aureus strains were grown to the midexponential growth phase, washed and resuspended in sterile PBS (pH 7.2). FITC (Sigma; 10 mg ml −1 in dimethylsulfoxide) was added to a final concentration of 30 µg ml -1 ; the solution was incubated at 37 °C for 1 h, washed three times with sterile PBS and resuspended in PBS at 10 6 CFU per µl. The percentage of FITC-labeled S. aureus was measured by flow cytometry with a FACSCalibur (BD) and was >95%. Then, 10 7 CFU of FITC-labeled S. aureus in 10 µl PBS was pipetted slowly into 100 µl heparinized blood (10:1 ratio of S. aureus to blood cells), mixed gently and incubated at 37 °C. Control samples were treated equally but were incubated at 4 °C to correct for the nonspecific adherence of FITC-labeled S. aureus to neutrophils. The tubes were incubated for the appropriate time periods, and red blood cells were lysed with ammonium chloride lysing solution using a standard protocol. Percentage phagocytosis of FITC-labeled S. aureus by neutrophils was calculated using the following equation: percentage phagocytosed cells at 37 °C − percentage phagocytosed cells at 4 °C.
Extraction and analysis of PSMs from the bacterial cytosol. Equal amounts of bacterial cells were harvested from bacterial cultures grown for 12 h by centrifugation (3,700g, 15 min). The cell pellets were washed twice with 6 M guanidinium hydrochloride, resuspended in 800 µl of 6 M guanidinium hydrochloride and lysed using glass beads. The bacterial cell lysates were centrifuged in an ultracentrifuge at 105,000g for 1 h to collect the bacterial cytosolic phase, and the cleared supernatant samples were measured using RP-HPLC/ESI-MS for PSM detection.
Transmission electron microscopy. Cultures were fixed in suspension overnight at 4 °C with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2. Samples were post-fixed for 30 min with 0.5% osmium tetroxide and 0.8% potassium ferricyanide in 0.1 M sodium cacodylate, for 1 hour with 1% tannic acid and overnight with 1% uranyl acetate at 4 °C. Samples were dehydrated with a graded ethanol series and embedded in Spurr's resin. Thin sections were cut with a Leica EM UC6 ultramicrotome (Leica) and stained with 1% uranyl acetate and Reynold's lead citrate before viewing at 120 kV npg on a Tecnai BT Spirit transmission electron microscope (FEI). Digital images were acquired with a Hamamatsu XR-100 side mount digital camera system (Advanced Microscopy Techniques).
Bacterial killing assay. Bacterial killing assays were performed as described 35 with some variations. The assays were performed in 96-well plates with approximately 10 6 bacterial cells per well. The bacteria were grown in carbonatecontaining medium for 3 h. PSMs were added at the indicated concentrations, and the assay plates were incubated at 37 °C for 3 h. Bacteria were plated in appropriate dilutions on tryptic soy agar plates for the enumeration of CFU.
Analysis of biofilms using confocal laser scanning microscopy. Static biofilms were grown in eight-well chambered coverglass plates (Lab-Tek) and analyzed on a Zeiss LSM 700 confocal microscope after gentle washing and staining with propidium iodide (10 µM) for 15 min, as described 9 .
Tricine SDS-PAGE. Tricine SDS-PAGE was performed in 16% acrylamide and bis-acrylamide (19:1) gels. The applied voltage gradient was 50 V for 1.5 h, 100 V for 1.5 h and 130 V for 18 h. Twenty-eight microliters of each sample was loaded per well.
Preparation of culture filtrates for gel electrophoresis and HPLC. Culture filtrates from 50-ml S. aureus cultures grown for 12 h were precipitated using 10% ice-cold trichloroacetic acid (TCA). TCA pellets were resuspended in 500 µl of 7 M urea, 2 M thiourea, 4% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate and 30 mM tris(hydroxymethyl)aminomethane. For HPLC analyses, samples were diluted 1:10 in the same buffer, and 100 µl of each dilution was injected onto the column. For electrophoresis, samples were diluted 1:4 with water.
Bioinformatic and statistical analyses. Statistical analyses were performed using GraphPad Prism 5.04. Direct comparisons between two groups were analyzed using two-tailed t tests, and comparisons between two groups among a set of groups were analyzed by one-way or two-way ANOVA, as appropriate, and Bonferroni post tests. Error bars show the s.e.m. Protein sequence analysis was performed using BLASTP or ClustalW, and pinned region analysis was performed on ERGO, as indicated.
